Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China · Delayed Price · Currency is CNY 9.63
+0.47 (5.13%)
Apr 29, 2026, 3:08 PM CST
SHE:300016 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 88.65 | 13.65 | -71.76 | 11.28 | 125.51 |
Depreciation & Amortization | 97.31 | 94.12 | 84.46 | 77.65 | 62.83 |
Other Amortization | 5.34 | 5.93 | 3.89 | 2.86 | 1.08 |
Loss (Gain) From Sale of Assets | 1.23 | -0.12 | -0.89 | -0.1 | -0.13 |
Asset Writedown & Restructuring Costs | -43.66 | 1.14 | 33.06 | 19.77 | 0.76 |
Loss (Gain) From Sale of Investments | -8.07 | 4.59 | 7.96 | -22.99 | -28.5 |
Provision & Write-off of Bad Debts | - | -0.94 | 3.64 | -0.88 | -1.45 |
Other Operating Activities | 45.37 | 54.83 | 58.01 | 38.78 | 28.87 |
Change in Accounts Receivable | -105.11 | 38.55 | -52.91 | 33.88 | 60.4 |
Change in Inventory | -24.09 | -86.91 | 24.71 | -27.03 | -131.04 |
Change in Accounts Payable | 96.07 | 35.81 | -9.58 | 10.13 | 36.48 |
Change in Other Net Operating Assets | -4.63 | 3.46 | -4.12 | -6.94 | -40.09 |
Operating Cash Flow | 156.57 | 163.02 | 58.46 | 127.81 | 108.73 |
Operating Cash Flow Growth | -3.96% | 178.86% | -54.26% | 17.55% | -38.22% |
Capital Expenditures | -218.87 | -101.39 | -144.61 | -102.78 | -147.76 |
Sale of Property, Plant & Equipment | 0.01 | 1.67 | 21.96 | 0.01 | 0.17 |
Cash Acquisitions | -0.87 | -148.61 | - | - | - |
Investment in Securities | 4.17 | -345.62 | 4.29 | 1.35 | -24.14 |
Other Investing Activities | -31.82 | 13.18 | 4.04 | 10.21 | 27.68 |
Investing Cash Flow | -247.38 | -580.76 | -114.32 | -91.21 | -144.04 |
Long-Term Debt Issued | 518.68 | 215.85 | 323.22 | 101 | 64.71 |
Total Debt Issued | 518.68 | 215.85 | 323.22 | 101 | 64.71 |
Long-Term Debt Repaid | -361.89 | -292.14 | -219.23 | -82.03 | -219.69 |
Total Debt Repaid | -361.89 | -292.14 | -219.23 | -82.03 | -219.69 |
Net Debt Issued (Repaid) | 156.79 | -76.29 | 103.99 | 18.97 | -154.98 |
Repurchase of Common Stock | - | - | -0.1 | -3.4 | -8.38 |
Common Dividends Paid | -37.42 | -20.9 | -50.72 | -52.54 | -44.9 |
Other Financing Activities | -12.04 | - | -0 | -123.32 | 108.3 |
Financing Cash Flow | 107.34 | -97.19 | 53.17 | -160.29 | -99.95 |
Foreign Exchange Rate Adjustments | -1.82 | 0.26 | -2.52 | 0.29 | -0.19 |
Net Cash Flow | 14.7 | -514.67 | -5.21 | -123.4 | -135.45 |
Free Cash Flow | -62.3 | 61.63 | -86.15 | 25.03 | -39.03 |
Free Cash Flow Margin | -5.17% | 6.27% | -9.67% | 3.27% | -4.54% |
Free Cash Flow Per Share | -0.12 | 0.14 | -0.18 | 0.04 | -0.08 |
Cash Income Tax Paid | 76.17 | 64.22 | 45.17 | 64.27 | 63 |
Levered Free Cash Flow | -144.97 | -24.13 | -156.23 | -58.31 | -112.52 |
Unlevered Free Cash Flow | -144.97 | 12.12 | -123.02 | -28.53 | -84.91 |
Change in Working Capital | -29.61 | -10.18 | -59.91 | 1.44 | -80.24 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.